From the Center for Metabolic and Vascular Biology, School of Life Sciences, Arizona State University, Tempe, Arizona 85287 and.
the Department of Biomedical Sciences, East Tennessee State University, Johnson City, Tennessee 37614.
J Biol Chem. 2018 May 4;293(18):6869-6882. doi: 10.1074/jbc.RA117.000515. Epub 2018 Mar 14.
Platelet factor 4 (PF4) is one of the most abundant cationic proteins secreted from α-granules of activated platelets. Based on its structure, PF4 was assigned to the CXC family of chemokines and has been shown to have numerous effects on myeloid leukocytes. However, the receptor for PF4 remains unknown. Here, we demonstrate that PF4 induces leukocyte responses through the integrin Mac-1 (αβ, CD11b/CD18). Human neutrophils, monocytes, U937 monocytic and HEK293 cells expressing Mac-1 strongly adhered to immobilized PF4 in a concentration-dependent manner. The cell adhesion was partially blocked by anti-Mac-1 mAb and inhibition was enhanced when anti-Mac-1 antibodies were combined with glycosaminoglycans, suggesting that cell-surface proteoglycans act cooperatively with Mac-1. PF4 also induced Mac-1-dependent migration of human neutrophils and murine WT, but not Mac-1-deficient macrophages. Coating of bacteria or latex beads with PF4 enhanced their phagocytosis by macrophages by ∼4-fold, and this process was blocked by different Mac-1 antagonists. Furthermore, PF4 potentiated phagocytosis by WT, but not Mac-1-deficient macrophages. As determined by biolayer interferometry, PF4 directly bound the αI-domain, the major ligand-binding region of Mac-1, and this interaction was governed by a of 1.3 ± 0.2 μm Using the PF4-derived peptide library, synthetic peptides duplicating the αI-domain recognition sequences and recombinant mutant PF4 fragments, the binding sites for αI-domain were identified in the PF4 segments Cys-Ser and Ala-Ser These results identify PF4 as a ligand for the integrin Mac-1 and suggest that many immune-modulating effects previously ascribed to PF4 are mediated through its interaction with Mac-1.
血小板因子 4(PF4)是从活化的血小板α颗粒中分泌的最丰富的阳离子蛋白之一。根据其结构,PF4 被分配到 CXC 趋化因子家族,并且已经显示出对髓样白细胞有许多影响。然而,PF4 的受体仍然未知。在这里,我们证明 PF4 通过整合素 Mac-1(αβ,CD11b/CD18)诱导白细胞反应。人中性粒细胞、单核细胞、表达 Mac-1 的 U937 单核细胞和 HEK293 细胞以浓度依赖的方式强烈地附着于固定化的 PF4。细胞粘附被抗 Mac-1 mAb 部分阻断,并且当抗 Mac-1 抗体与糖胺聚糖结合时抑制增强,表明细胞表面糖蛋白与 Mac-1 协同作用。PF4 还诱导人中性粒细胞和小鼠 WT 但不是 Mac-1 缺陷型巨噬细胞的 Mac-1 依赖性迁移。用 PF4 包被细菌或乳胶珠增强了巨噬细胞对其的吞噬作用约 4 倍,并且该过程被不同的 Mac-1 拮抗剂阻断。此外,PF4 增强了 WT 但不是 Mac-1 缺陷型巨噬细胞的吞噬作用。通过生物层干涉法测定,PF4 直接结合 Mac-1 的主要配体结合区αI 结构域,并且该相互作用受的控制 为 1.3±0.2μm。使用 PF4 衍生的肽文库、复制αI 结构域识别序列的合成肽和重组突变 PF4 片段,鉴定了 αI 结构域的结合位点在 PF4 片段 Cys-Ser 和 Ala-Ser 中。这些结果将 PF4 鉴定为整合素 Mac-1 的配体,并表明先前归因于 PF4 的许多免疫调节作用是通过其与 Mac-1 的相互作用介导的。